Gain Therapeutics Inc (GANX)
2.58
-0.11
(-4.09%)
USD |
NASDAQ |
May 17, 16:00
2.58
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics Price to Book Value: 3.327 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 3.469 |
| May 15, 2024 | 3.378 |
| May 14, 2024 | 3.017 |
| May 13, 2024 | 3.121 |
| May 10, 2024 | 3.237 |
| May 09, 2024 | 3.275 |
| May 08, 2024 | 3.456 |
| May 07, 2024 | 3.740 |
| May 06, 2024 | 3.675 |
| May 03, 2024 | 3.817 |
| May 02, 2024 | 3.778 |
| May 01, 2024 | 3.830 |
| April 30, 2024 | 3.778 |
| April 29, 2024 | 3.868 |
| April 26, 2024 | 3.907 |
| April 25, 2024 | 3.959 |
| April 24, 2024 | 4.114 |
| April 23, 2024 | 4.371 |
| April 22, 2024 | 4.088 |
| April 19, 2024 | 4.101 |
| April 18, 2024 | 4.062 |
| April 17, 2024 | 4.101 |
| April 16, 2024 | 4.075 |
| April 15, 2024 | 3.985 |
| April 12, 2024 | 4.062 |
| Date | Value |
|---|---|
| April 11, 2024 | 4.333 |
| April 10, 2024 | 4.307 |
| April 09, 2024 | 4.358 |
| April 08, 2024 | 4.423 |
| April 05, 2024 | 4.591 |
| April 04, 2024 | 4.616 |
| April 03, 2024 | 5.145 |
| April 02, 2024 | 5.016 |
| April 01, 2024 | 4.939 |
| March 28, 2024 | 4.861 |
| March 27, 2024 | 4.810 |
| March 26, 2024 | 4.900 |
| March 25, 2024 | 4.707 |
| March 22, 2024 | 5.235 |
| March 21, 2024 | 5.635 |
| March 20, 2024 | 5.493 |
| March 19, 2024 | 5.480 |
| March 18, 2024 | 5.622 |
| March 15, 2024 | 5.532 |
| March 14, 2024 | 5.519 |
| March 13, 2024 | 5.854 |
| March 12, 2024 | 5.880 |
| March 11, 2024 | 6.022 |
| March 08, 2024 | 6.099 |
| March 07, 2024 | 5.932 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9558
Minimum
May 24 2022
26.79
Maximum
Mar 30 2021
3.206
Average
2.581
Median
Jan 23 2023
Price to Book Value Benchmarks
| Eli Lilly and Co | 57.18 |
| Alpine Immune Sciences Inc | 13.40 |
| Outlook Therapeutics Inc | -- |
| OptiNose Inc | -- |
| Greenwich LifeSciences Inc | 27.04 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0486 |
| Price | 2.58 |
| Earnings Yield | -66.28% |
| Market Cap | 41.85M |
| PEGY Ratio | -0.0486 |